Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03314987 · ClinicalTrials.gov registry record · NA

Nucleophilic Defense Against PM Toxicity (NEAT Trial)

A NA study of Air Pollution Toxicity, sponsored by University of Louisville.

Completed
Registry status
NA
Development phase
299
Enrollment target
1
Study location

NCT03314987 is a NA study of Air Pollution Toxicity that has completed, run by University of Louisville. The registered enrollment target is 299 participants. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03314987, a NA study of Air Pollution Toxicity, has completed, sponsored by University of Louisville.

COMPLETED
Registry status
NA
Development phase
299 participants
Enrollment target
1
Study location

Study Summary

Carnosine is a naturally occurring peptide found in high levels in skeletal muscle and the brain and is also available commercially as a dietary supplement. Since carnosine has anti-oxidant properties and air pollution exposure induces a state of oxidative stress, the purpose of this study is to see if those taking carnosine as a dietary supplement are protected from air pollution-induced oxidative stress and adverse cardiovascular outcomes.

Conditions Studied

Interventions

  • OTHER placebo
  • DIETARY_SUPPLEMENT L-carnosine

Study Locations (1)

Kentucky

  • Clinical Trials Unit - Louisville

Trial Details

FieldValue
Enrollment Target 299 participants
Start Date 2018-04-01
Est. Completion 2022-11-01
Phase NA

Sponsor

University of Louisville

217 total trials

What the Registry Record Tells You About NCT03314987

The ClinicalTrials.gov registry entry for NCT03314987 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 299 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Louisville, which has 217 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Air Pollution Toxicity appearing as the primary indexed condition, and to 2 interventions - of which placebo is the first listed.

NCT03314987 reports 1 study location spanning 1 distinct geographic area - top geographies include Kentucky.

Frequently Asked Questions

What is clinical trial NCT03314987 about?

NCT03314987 is a clinical study titled "Nucleophilic Defense Against PM Toxicity (NEAT Trial)". Carnosine is a naturally occurring peptide found in high levels in skeletal muscle and the brain and is also available commercially as a dietary supplement. Since carnosine has anti-oxidant properties and air pollution exposure induces a state of oxidative stress, the purpose of this study is to see...

What is the current status of trial NCT03314987?

This trial is currently completed. It is a NA study. The enrollment target is 299 participants. The study started on 2018-04-01. Estimated completion is 2022-11-01.

What conditions does trial NCT03314987 study?

This clinical trial studies the following conditions: Air Pollution Toxicity.

What interventions are being tested in trial NCT03314987?

The interventions under investigation include: placebo (OTHER), L-carnosine (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT03314987?

This trial is sponsored by University of Louisville, which has 217 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03314987 being conducted?

This trial has 1 study location across Kentucky. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.